Media formats available:
Recommended
- CDMC 2018: Shifting gears in the management of diabetes and CVDTwo choices of drugs that reduce CV risk in T2DM
Prof. John Deanfield, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: The GLP1 landscape - refining our understanding
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Screening for Diabetes: When is it meaningful and how should it be performed
Prof. Lars Rydén
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Targeting CV risk: Implications for clinical management of patients with T2DM & CVD
Prof. Richard Hobbs, MD